These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 7872744)
1. Comparative efficacies of amphotericin B, triazoles, and combination of both as experimental therapy for murine trichosporonosis. Anaissie EJ; Hachem R; Karyotakis NC; Gokaslan A; Dignani MC; Stephens LC; Tin-U CK Antimicrob Agents Chemother; 1994 Nov; 38(11):2541-4. PubMed ID: 7872744 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of amphotericin B and azoles alone and in combination against disseminated trichosporonosis in neutropenic mice. Kamberi P; Atsuro H; Takayoshi T; Masaru N Chemotherapy; 1998; 44(1):55-62. PubMed ID: 9444410 [TBL] [Abstract][Full Text] [Related]
3. Activities of D0870, a novel triazole, against Candida lusitaniae and Trichosporon beigelii in experimental murine infections. Karyotakis NC; Dignani MC; Hachem R; Anaissie EJ Antimicrob Agents Chemother; 1995 Feb; 39(2):571-3. PubMed ID: 7726538 [TBL] [Abstract][Full Text] [Related]
4. Azole therapy for trichosporonosis: clinical evaluation of eight patients, experimental therapy for murine infection, and review. Anaissie E; Gokaslan A; Hachem R; Rubin R; Griffin G; Robinson R; Sobel J; Bodey G Clin Infect Dis; 1992 Nov; 15(5):781-7. PubMed ID: 1445976 [TBL] [Abstract][Full Text] [Related]
5. SCH 51048, a new antifungal triazole active against hematogenous Candida krusei infections in neutropenic mice. Karyotakis NC; Dignani MC; Anaissie EJ Antimicrob Agents Chemother; 1995 Mar; 39(3):775-7. PubMed ID: 7793892 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic efficacy of posaconazole in a murine model of disseminated trichosporonosis. Treviño-Rangel Rde J; López LJ; Palma-Nicolás JP; Hernández-Bello R; González JG; González GM J Antimicrob Chemother; 2014 Apr; 69(4):1075-8. PubMed ID: 24252752 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of micafungin in combination with other drugs in a murine model of disseminated trichosporonosis. Serena C; Pastor FJ; Gilgado F; Mayayo E; Guarro J Antimicrob Agents Chemother; 2005 Feb; 49(2):497-502. PubMed ID: 15673724 [TBL] [Abstract][Full Text] [Related]
8. Voriconazole versus amphotericin B in cancer patients with neutropenia. Jørgensen KJ; Gøtzsche PC; Johansen HK Cochrane Database Syst Rev; 2006 Jan; (1):CD004707. PubMed ID: 16437492 [TBL] [Abstract][Full Text] [Related]
9. Comparison of amphotericin B lipid complex with amphotericin B and SCH 39304 in the treatment of murine coccidioidal meningitis. Allendoerfer R; Yates RR; Sun SH; Graybill JR J Med Vet Mycol; 1992; 30(5):377-84. PubMed ID: 1469539 [TBL] [Abstract][Full Text] [Related]
10. Experimental disseminated trichosporonosis in mice: tissue distribution and therapy with antifungal agents. Yamamoto K; Makimura K; Sudo T; Shibuya K; Uchida K; Yamaguchi H J Med Vet Mycol; 1997; 35(6):411-8. PubMed ID: 9467108 [TBL] [Abstract][Full Text] [Related]
11. Successful Treatment of Breakthrough Trichosporon asahii Fungemia by the Combination Therapy of Fluconazole and Liposomal Amphotericin B in a Patient with Follicular Lymphoma. Itoh K; Iwasaki H; Negoro E; Shigemi H; Tokimatsu I; Tsutani H; Yamauchi T Mycopathologia; 2021 Mar; 186(1):113-117. PubMed ID: 33389484 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the efficacy of polyenes and triazoles against hematogenous Candida krusei infection in neutropenic mice. Karyotakis NC; Anaissie EJ; Hachem R; Dignani MC; Samonis G J Infect Dis; 1993 Nov; 168(5):1311-3. PubMed ID: 8228370 [TBL] [Abstract][Full Text] [Related]
13. Pathogenicity of Trichosporon asahii in a murine model of disseminated trichosporonosis. Yang RY; Wang WL; Ao JH; Hao ZF; Zhang J; Wang CM Chin Med J (Engl); 2008 Dec; 121(24):2557-60. PubMed ID: 19187595 [TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo activities of Sch 39304, fluconazole, and amphotericin B against Histoplasma capsulatum. Kobayashi GS; Travis SJ; Rinaldi MG; Medoff G Antimicrob Agents Chemother; 1990 Apr; 34(4):524-8. PubMed ID: 2344160 [TBL] [Abstract][Full Text] [Related]
15. The development of animal infection models and antifungal efficacy assays against clinical isolates of Trichosporon asahii, T. asteroides and T. inkin. Mariné M; Bom VL; de Castro PA; Winkelstroter LK; Ramalho LN; Brown NA; Goldman GH Virulence; 2015; 6(5):476-86. PubMed ID: 25751127 [TBL] [Abstract][Full Text] [Related]
16. Fungemia due to Trichosporon asahii in a neutropenic child refractory to amphotericin B: clearance with voriconazole. Antachopoulos C; Papakonstantinou E; Dotis J; Bibashi E; Tamiolaki M; Koliouskas D; Roilides E J Pediatr Hematol Oncol; 2005 May; 27(5):283-5. PubMed ID: 15891566 [TBL] [Abstract][Full Text] [Related]
17. Breakthrough trichosporonosis in a bone marrow transplant recipient receiving caspofungin acetate. Goodman D; Pamer E; Jakubowski A; Morris C; Sepkowitz K Clin Infect Dis; 2002 Aug; 35(3):E35-6. PubMed ID: 12115115 [TBL] [Abstract][Full Text] [Related]
18. Treatment of murine pulmonary blastomycosis with SCH 39304, a new triazole antifungal agent. Sugar AM; Picard M; Noble L Antimicrob Agents Chemother; 1990 May; 34(5):896-8. PubMed ID: 2360825 [TBL] [Abstract][Full Text] [Related]
19. Disseminated neonatal Trichosporon beigelii infection: successful treatment with liposomal amphotericin B. Sweet D; Reid M J Infect; 1998 Jan; 36(1):120-1. PubMed ID: 9515683 [TBL] [Abstract][Full Text] [Related]
20. Therapies against murine Candida guilliermondii infection, relationship between in vitro antifungal pharmacodynamics and outcome. Paredes K; Pastor FJ; Capilla J; Sutton DA; Mayayo E; Fothergill AW; Guarro J Rev Iberoam Micol; 2015; 32(1):34-9. PubMed ID: 24594291 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]